Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis

Open access

Abstract

Given the growing evidence of a link between gut microbiota (GM) dysbiosis and multiple sclerosis (MS), fecal microbiota transplantation (FMT), aimed at rebuilding GM, has been proposed as a new therapeutic approach to MS treatment. To evaluate the viability of FMT for MS treatment and its impact on MS pathology, we tested FMT in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We provide evidence that FMT can rectify altered GM to some extent with a therapeutic effect on EAE. We also found that FMT led to reduced activation of microglia and astrocytes and conferred protection on the blood-brain barrier (BBB), myelin, and axons in EAE. Taken together, our data suggest that FMT, as a GM-based therapy, has the potential to be an effective treatment for MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2020/2058272

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 FMT modulates GM in EAE. (a) Chart of the Shannon index values for evaluation of GM α-diversity. The Shannon index for GM was significantly increased in EAE mice (n = 6) compared to normal controls (CON, n = 5); an in-between value was found in FMT-treated immunized mice (FMT; n = 6) without statistical significance. (b) Chart of relative abundance of gut bacterial taxa (phylum level) performed with the Mann–Whitney U test, corrected by FDR between the two groups. The figure was created by used unfiltered OUT table. (c) PCoA plot (PC1/PC2) of unweighted UniFrac distances illustrating clustering separation between samples from different mouse groups. (d) Hierarchical clustering tree on OTU level (weighted UniFrac). (e) The correlation heatmap chart performed with a Spearman's correlation of bacterial abundance with EAE scores and cumulative scores. The R value is shown in different colors in the figure. The legend on the right is the color interval of different R values (∗0.01 < p < 0.05 and ∗∗0.001 < p < 0.01). (f) LEfSe cladogram showing differentially abundant gut bacterial taxa. The diameter of each dot is proportional to its effect size. Each ring (from inside to outside) represents a taxonomic level from kingdom to genus, the cladogram was made on filtered data, and only taxa with greater than 0.1% relative abundance. (g) LDA scores of abundant gut bacterial taxa (LDA score threshold >2.0). k: kingdom; p: phylum; c: class; o: order; f: family; g: genus.
Figure 1 FMT modulates GM in EAE. (a) Chart of the Shannon index values for evaluation of GM α-diversity. The Shannon index for GM was significantly increased in EAE mice (n = 6) compared to normal controls (CON, n = 5); an in-between value was found in FMT-treated immunized mice (FMT; n = 6) without statistical significance. (b) Chart of relative abundance of gut bacterial taxa (phylum level) performed with the Mann–Whitney U test, corrected by FDR between the two groups. The figure was created by used unfiltered OUT table. (c) PCoA plot (PC1/PC2) of unweighted UniFrac distances illustrating clustering separation between samples from different mouse groups. (d) Hierarchical clustering tree on OTU level (weighted UniFrac). (e) The correlation heatmap chart performed with a Spearman's correlation of bacterial abundance with EAE scores and cumulative scores. The R value is shown in different colors in the figure. The legend on the right is the color interval of different R values (∗0.01 < p < 0.05 and ∗∗0.001 < p < 0.01). (f) LEfSe cladogram showing differentially abundant gut bacterial taxa. The diameter of each dot is proportional to its effect size. Each ring (from inside to outside) represents a taxonomic level from kingdom to genus, the cladogram was made on filtered data, and only taxa with greater than 0.1% relative abundance. (g) LDA scores of abundant gut bacterial taxa (LDA score threshold >2.0). k: kingdom; p: phylum; c: class; o: order; f: family; g: genus.CC BY · PubMed Central
Figure 2 FMT has a therapeutic effect on EAE. (a) Chart of clinical scores for EAE controls and FMT-treated immunized mice after EAE induction. FMT led to decreased clinical scores through the clinical course of EAE (mean ± SEM; n = 10/group; ∗∗p < 0.01). (b, c) Charts of cumulative clinical scores (b) and disease onset days (c) after EAE induction indicating reduced clinical severity and delayed disease onset after FMT treatment (mean ± SEM; n = 10/group; ∗p < 0.05 and ∗∗∗p < 0.001).
Figure 2 FMT has a therapeutic effect on EAE. (a) Chart of clinical scores for EAE controls and FMT-treated immunized mice after EAE induction. FMT led to decreased clinical scores through the clinical course of EAE (mean ± SEM; n = 10/group; ∗∗p < 0.01). (b, c) Charts of cumulative clinical scores (b) and disease onset days (c) after EAE induction indicating reduced clinical severity and delayed disease onset after FMT treatment (mean ± SEM; n = 10/group; ∗p < 0.05 and ∗∗∗p < 0.001).CC BY · PubMed Central
Figure 3 FMT prevents BBB leakage in EAE. (a) Claudin 5 expression in thoracic spinal cord tissues collected from EAE controls and FMT-treated EAE mice revealed by Western blot with β-tubulin as loading control. (b) Chart of quantified Western blot results showing increased levels of Claudin 5 expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗∗p < 0.01). (c) Representative immunostaining images of Claudin 5 expression (green) in spinal cord sections. The nucleus was stained with Hoechst (blue). Scale bar: 100 μm. (d) Representative images of Evans blue dye extravasation (red) in the subcortical white matter of brain showing the presence of dye in both blood vessels and brain parenchyma in EAE controls (upper panels) in contrast to appreciably reduced dye presence in brain parenchyma in FMT-treated EAE mice (lower panels). Each right panel shows a high magnification image of the area inside the white box (left). Scale bars: 400 μm (left) and 200 μm (right). Representative brain parenchyma and blood vessels are indicated by arrowheads and arrows, respectively.
Figure 3 FMT prevents BBB leakage in EAE. (a) Claudin 5 expression in thoracic spinal cord tissues collected from EAE controls and FMT-treated EAE mice revealed by Western blot with β-tubulin as loading control. (b) Chart of quantified Western blot results showing increased levels of Claudin 5 expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗∗p < 0.01). (c) Representative immunostaining images of Claudin 5 expression (green) in spinal cord sections. The nucleus was stained with Hoechst (blue). Scale bar: 100 μm. (d) Representative images of Evans blue dye extravasation (red) in the subcortical white matter of brain showing the presence of dye in both blood vessels and brain parenchyma in EAE controls (upper panels) in contrast to appreciably reduced dye presence in brain parenchyma in FMT-treated EAE mice (lower panels). Each right panel shows a high magnification image of the area inside the white box (left). Scale bars: 400 μm (left) and 200 μm (right). Representative brain parenchyma and blood vessels are indicated by arrowheads and arrows, respectively.CC BY · PubMed Central
Figure 4 FMT confers protection on myelin and axons in EAE. (a) MBP and NF-L protein expression in the brain of EAE controls and FMT-treated EAE mice shown by Western blot with β-tubulin as loading control. (b, c) Charts of quantified Western blot results showing increased levels of MBP (b) and decreased levels of NF-L (c) expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗p < 0.05 and ∗∗p < 0.01). (d) Immunofluorescence imaging of MBP (green) and NF-L (red) expression in the corpus callosum of the mouse brain. Nuclear staining was by Hoechst (blue). Each rightmost panel shows a high magnification image of the area inside the white box. Scale bar: 25 μm. (e) Transmission electron microscopy (TEM) imaging of myelin sheaths in the thoracic spinal cord. Each high magnification image (right) shows the area enclosed by the white box (left). Representative normal and damaged myelin sheaths are indicated by arrowheads and arrows, respectively.
Figure 4 FMT confers protection on myelin and axons in EAE. (a) MBP and NF-L protein expression in the brain of EAE controls and FMT-treated EAE mice shown by Western blot with β-tubulin as loading control. (b, c) Charts of quantified Western blot results showing increased levels of MBP (b) and decreased levels of NF-L (c) expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗p < 0.05 and ∗∗p < 0.01). (d) Immunofluorescence imaging of MBP (green) and NF-L (red) expression in the corpus callosum of the mouse brain. Nuclear staining was by Hoechst (blue). Each rightmost panel shows a high magnification image of the area inside the white box. Scale bar: 25 μm. (e) Transmission electron microscopy (TEM) imaging of myelin sheaths in the thoracic spinal cord. Each high magnification image (right) shows the area enclosed by the white box (left). Representative normal and damaged myelin sheaths are indicated by arrowheads and arrows, respectively.CC BY · PubMed Central
Figure 5 FMT alleviates immune cells and astrocyte activation in EAE. (a). Expression of Iba1 and GFAP protein in the brain of EAE controls and FMT-treated EAE mice shown by Western blot with β-tubulin as loading control. (b, c). Charts of quantified Western blot results indicating reduced levels of Iba1(b) and GFAP (c) expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗p < 0.05). (d, e) Immunofluorescence imaging of cells expressing Iba1 (green; d) and GFAP (green; e) in brain sections with the nucleus stained by Hoechst (blue). Scale bar: 100 μm.
Figure 5 FMT alleviates immune cells and astrocyte activation in EAE. (a). Expression of Iba1 and GFAP protein in the brain of EAE controls and FMT-treated EAE mice shown by Western blot with β-tubulin as loading control. (b, c). Charts of quantified Western blot results indicating reduced levels of Iba1(b) and GFAP (c) expression (normalized by β-tubulin) after FMT treatment (mean ± SEM; n = 6/group; ∗p < 0.05). (d, e) Immunofluorescence imaging of cells expressing Iba1 (green; d) and GFAP (green; e) in brain sections with the nucleus stained by Hoechst (blue). Scale bar: 100 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 92

Metadata

Authors
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., Ma, G., Liu, Z., Li, H., & Zhao, B.
Affiliations
  • Guangdong Medical College (CN)
  • University College London (GB)
Corresponding author
  • Liu, Zhou
  • Li, Huiliang
  • Zhao, Bin
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2020-08-05
Volume
2020
Pages
1-13
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W3047080278
Cited by
92
References
66
Citations by year
2026: 3 · 2025: 15 · 2024: 17 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 1
FWCI
9.37
Type
journal article
Language
en
Open access
Locations
  • Mediators of Inflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Affiliated Hospital of GMU (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • GMU (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • Traditional Chinese Medicine Bureau of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • Medical Scientific Research Foundation of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • Science and Technology Planning Project of Zhanjiang (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • Ordinary Colleges and Universities in Guangdong (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • Natural Science Foundation of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
  • National Natural Science Foundation of China (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords
fecal microbiota transplantation, multiple sclerosis, experimental autoimmune encephalomyelitis, gut dysbiosis, microglial activation, astrocyte activation, blood-brain barrier, myelin, axons, neuroprotection, microbiota-based therapy
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Axons, Blood-Brain Barrier, Disease Models, Animal, Feces, Female, Fluorescent Antibody Technique, Mice, Inbred C57BL, Multiple Sclerosis, Myelin Sheath, RNA, Ribosomal, 16S, Blotting, Western, Microscopy, Electron, Transmission, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis. https://app.cochat.ai/papers/10.1155/2020/2058272
The paper
Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., Ma, G., Liu, Z., Li, H., & Zhao, B. (2020). Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis. Mediators of Inflammation. https://doi.org/10.1155/2020/2058272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.